ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Healthcare Shares
Here's why the ResMed share price is charging higher today
Healthcare Shares
3 ASX 300 healthcare share winners on Wednesday
Share Market News
Here are the top 10 ASX 200 shares today
Broker Notes
Morgans names 3 more of the best ASX shares to buy in September
Growth Shares
Broker names 2 excellent ASX growth shares to buy right now
Growth Shares
3 top ASX growth shares analysts rate as buys
Blue Chip Shares
3 buy-rated ASX 200 shares that analysts love
Blue Chip Shares
Brokers name 2 blue chip ASX 200 shares to buy
Healthcare Shares
Why 'the outlook is very bullish' for the Resmed share price: Tribeca
Broker Notes
Why this broker sees plenty of upside for the ResMed share price
Broker Notes
Leading brokers name 3 ASX shares to buy today
Healthcare Shares
The ASX 200 company selling everything it makes due to its major competitor being out of the market: fundie
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
